Source: ERJ Open Res, 4 (3) 00033-2018; 10.1183/23120541.00033-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Tina Heyder, Emil Wiklundh, Anders Eklund, Anna James, Sven-Erik Dahlén, Johan Grunewald, Roman A. Zubarev, Susanna L. Lundström. Altered Fc galactosylation in IgG₄ is a potential serum marker for chronic lung disease. ERJ Open Res, 4 (3) 00033-2018; 10.1183/23120541.00033-2018

Member's Comments

No comment yet.

Related content which might interest you: IgG4 disease and the lung Source: International Congress 2016 – Lung involvement in systemic disorders Year: 2016 High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Altered IgG but normal IgA responses to pneumococcal proteins in lung fluid and serum in HIV infected adults Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 An association between sarcoidosis and serum immunoglobulin levels Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Serum immunoglobulin level is a useful marker for the risk of opportunistic infection in steroid dependent patients with chronic inflammatory airway diseases Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The importance of quantifying serum antibody associated with allergic alveolitis Source: Eur Respir J 2004; 24: Suppl. 48, 355s Year: 2004 Sputum autoantibodies are more relevant in autoimmune responses in asthma than are serum autoantibodies Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Mannose binding lectin (MBL) levels predict lung function decline in severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 599s Year: 2006 Mannose binding lectin (MBL) levels predict lung function decline in severe asthma Source: Eur Respir Rev 2006; 15: 224-225 Year: 2006 Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Serum IgG and IgA antibodies to chramydia pneumoniae and severity of emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004 Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia Source: International Congress 2016 – Orphan diseases II Year: 2016 Correlation between total serum immunoglobulin E and allergen specific immunoglobulin E in children with allergic disease Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009 Do serum levels of compleman component and immunoglobulins correlate with the degree of emphysema in cases with chronic bronchitis? Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005 Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 KL-6 is a useful serum biomarker for early detection of interstitial lung disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Serum KL-6 as a marker of disease progression in SSc-ILD Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012